It is with great sadness that Celgene Corporation (NASDAQ:CELG) announces the death of Rodman L. Drake, a member of its Board of Directors since 2006.We are deeply saddened by the passing of Rod Drake,” said Bob Hugin, Chairman and Chief Executive Officer of Celgene Corporation. “Rod was a valued member of our Board and brought a wealth of experience in corporate governance, finance and strategy to Celgene.Celgene Corporation (NASDAQ:CELG) net profit margin is 19.90% and weekly performance is 3.26%. On last trading day company shares ended up $88.50. Analysts mean target price for the company is $95.94. Celgene Corporation (NASDAQ:CELG) distance from 50-day simple moving average is 14.28%.
Omeros (NASDAQ:OMER) Director Peter A. Md Demopulos bought 6,153 shares of the stock in a transaction dated Tuesday, June 24th. The shares were purchased at an average cost of $16.20 per share, with a total value of $99,678.60. Following the purchase, the director now directly owns 181,220 shares of the company’s stock, valued at approximately $2,935,764. The purchase was disclosed in a legal filing with the Securities & Exchange Commission. Omeros Corporation (NASDAQ:OMER) shares advanced 3.97% in last trading session and ended the day on $18.09. OMER its return on assets is -170.50%. Omeros Corporation (NASDAQ:OMER) quarterly performance is 44.95%.
Orthofix International (NASDAQ: OFIX) popped higher on a recent insider trade disclosure.According to a Form 4 filed with the U.S. SEC, CFO Mark Heggestad acquired 13,696 shares on June 10th at an average price of $33.2545 per share. Following the purchase, the executive holds 46,696 shares.Orthofix International NV (NASDAQ:OFIX) shares moved up 1.05% in last trading session and was closed at $36.63, while trading in range of $36.19-$36.83. Orthofix International NV (NASDAQ:OFIX) year to date performance is 60.52%.
On June 20 2014 Shares of CareFusion Corporation (CFN) escalated nearly 1.0% following the commercial launch of its new micro-laparoscopic line of surgical instruments, MicroLap. This new line of surgical instruments helps surgeons perform any type of laparoscopic surgery without any limitations on specialty or procedural uses.CareFusion Corporation (NYSE:CFN) ended the last trading day at $45.26. Company weekly volatility is calculated as 1.35% and price to cash ratio as 5.98. CareFusion Corporation (NYSE:CFN) showed a positive weekly performance of 2.84%.
Taro Pharmaceutical Industries Ltd. Analyst Notes On May 27, 2014, Taro Pharmaceutical Industries Ltd. (Taro) reported its Q4 FY 2014 and FY 2014 financial results (period ended March 31, 2014). Q4 FY 2014 net sales increased 13.3% YoY to $187.2 million, while FY 2014 net sales increased 13.2% YoY to $759.3 million. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) net profit margin is 55.20% and weekly performance is 787%. On last trading day company shares ended up $141.98. Analysts mean target price for the company is $150.00. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) distance from 50-day simple moving average is 27.11%.